The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosis.
Sharrack B, Hughes RA, Morris RW, Soudain S, Wade-Jones O, Barnes D, Brown P, Britton T, Francis DA, Perkin GD, Rudge P, Swash M, Katifi HA, Farmer S, Frankel JP.
Sharrack B, et al. Among authors: perkin gd.
J Neurol Sci. 2000 Feb 1;173(1):73-7. doi: 10.1016/s0022-510x(99)00304-4.
J Neurol Sci. 2000.
PMID: 10675582
Clinical Trial.